Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Prostaglandins Other Lipid Mediat. 2020 Oct 1;152:106485. doi: 10.1016/j.prostaglandins.2020.106485

Figure 1:

Figure 1:

(A) Body weight over a period of 15 weeks of feeding high fat diet (HFD) or control diet (CD), with or without supplementation of doxycycline (DOX) to induce Cyp4a12 overexpression and/or 20-SOLA, a selective 20-HETE antagonist. (B) Cumulative body weight gain post 15 weeks on respective diet feeding (n=6-8 per group); ***p<0.001 ****p<0.0001 using repeated-measures two-way ANOVA with post-hoc Tukey’s test.